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We describe a three-protein signal-trans-
duction pathway that governs immunity to
a protein toxin involved in cannibalism by
the spore-forming bacterium Bacillus sub-
tilis. Cells of B. subtilis enter the pathway to
sporulate under conditions of nutrient limi-
tation but delay becoming committed to
spore formation by killing nonsporulating
siblings and feeding on the dead cells. Kill-
ing is mediated by the exported toxic pro-
tein SdpC. We report that extracellular
SdpC induces the synthesis of an immunity
protein, SdpI, that protects toxin-producing
cells from being killed. SdpI, a polytopic
membrane protein, is encoded by a two-
gene operon under sporulation control
that contains the gene for an autorepressor,
SdpR. The autorepressor binds to and
blocks the promoter for the operon. Evi-
dence indicates that SdpI is also a signal-
transduction protein that responds to the
SdpC toxin by sequestering the SdpR
autorepressor at the membrane. Seques-
tration relieves repression and stimulates
synthesis of immunity protein.
INTRODUCTION
Microbial cells respond to stress by inducing the expression
of an appropriate suite of adaptive (stress-response) genes
that help the cells cope with adverse environmental circum-
stances. Generally, the response to adverse conditions is
rapid and reversible and involves the coordinate induction
of the stress-response genes. Under certain conditions, cer-tain microbes respond to stress in a more elaborate manner,
an extreme example of which is endospore formation in
Bacillus subtilis. Endospore (or more simply, spore) forma-
tion, which is triggered by nutrient limitation, is a complex de-
velopmental process that involves the expression of more
than 500 genes over the course of 6 to 8 hr (Britton et al.,
2002; Eichenberger et al., 2004; Fujita et al., 2005; Molle
et al., 2003; Steil et al., 2003). The process culminates in
the formation of a resting cell that is capable of resisting en-
vironmental extremes and remaining dormant for long pe-
riods of time. It might be expected that the decision to com-
mit to spore formation is not taken lightly since converting
a cell into a spore requires a large investment of time and en-
ergy and because the process becomes irreversible after
about 2 hr (Dworkin and Losick, 2005; Parker et al., 1996).
Indeed, evidence indicates that, under conditions of high
cell population density (colonies), the bacterium forestalls
committing itself for as long as possible by a process of
cannibalism (Gonzalez-Pastor et al., 2003), a central aspect
of which is the subject of this report.
The master regulator for entry into sporulation is the re-
sponse regulator Spo0A, which is activated by phosphoryla-
tion (Burbulys et al., 1991). Spo0A is activated in response to
nutrient limitation, but only about half of the cells in the pop-
ulation activate the master regulator under nutrient-limiting
conditions (Chung et al., 1994; Fujita et al., 2005; Gonzalez-
Pastor et al., 2003). Evidence indicates that activation of
Spo0A is subject to a bistable switch and that the switch is
mediated by a positive-feedback loop involving the gene for
Spo0Aandgenes for proteins that govern its phosphorylation
(Veening et al., 2005). The generation of a mixed population
of cells in which Spo0A is active (Spo0A-ON) or in which it
is not (Spo0A-OFF) is the basis for cannibalism (Figure 1A).
In Spo0A-ON cells, the master regulator switches on the
transcription of two operons, skfA-H and sdpABC, that are
responsible, respectively, for the production and export of
a peptide-antibiotic-like killing factor and a protein toxin
that kill Spo0A-OFF siblings (Figure 1A). Nutrients released
from the dead cells slow down or prevent Spo0A-ON cells
from reaching the stage of development when sporula-
tion becomes irreversible. Thus, by killing their Spo0A-OFFCell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc. 549
Figure 1. Cannibalism and the Induction of Immunity Protein
(A) A model for cannibalism depicting a cell in which Spo0A is activated (Spo0A-ON in the text) and a cell in which it is not (Spo0A-OFF). Spo0A-ON cells
produce and export a peptide killing factor and the SdpC toxin, which kill Spo0A-OFF siblings. The dead cells release nutrients that arrest sporulation by
Spo0A-ON cells.
(B) The panel depicts the convergent sdpABC and sdpRI operons and identifies genes encoding toxin, immunity protein, and autorepressor. The bent ar-
rows represent promoters. The lines above the operons denote the deletions used in this study. The line below the operon indicates the sdpI-containing
DNA segment used for complementation.
(C) Sequestration model for how extracellular SdpC induces expression of the sdpRI immunity operon. The thick arrow on the right denotes high-level tran-
scription, and the thick symbol for SdpI on the right indicates its presence in high abundance.
(D) Amino acid substitutions of SdpI that rendered expression of the sdpRI operon independent of (green stars) or refractory to (red octagons) SdpC. The
SdpC-independent amino acid substitutions were I6T, I50T, F78I, M84T, L85S, and I98K, and the refractory substitutions were Q126L and S156T.siblings, Spo0A-ON cells delay becoming committed to
spore formation.
How do Spo0A-ON cells avoid killing themselves? In the
case of the killing factor, the answer is evidently simple.
The skfA-H operon contains the genes for the biosynthesis
of the inferred, peptide-like antibiotic as well as the genes
for an export pump that transports the killing factor out of
the producing cells and prevents self-killing (Gonzalez-
Pastor et al., 2003). Thus, Spo0A switches on both the prod-
uction of the killing factor and the protective export pump.
Since Spo0A-OFF cells do not express skfA-H, they produce
neither killing factor nor the pump that confers resistance to it
(Gonzalez-Pastor et al., 2003).
In contrast, the basis for self-resistance to the toxin has
been mysterious. The toxin (SdpC*) is a 63 amino acid pro-
tein that is derived from the C-terminal portion of the product
of sdpC, the third member of the three-gene sdpABC op-
eron (Figure 1B). All three genes are needed for production550 Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc.and export of the toxin (hereafter simply referred to as
SdpC). A striking feature of SdpC is that it is an intercellular,
signaling protein that induces the expression of an adjacent,
convergent, two-gene operon herein referred to as sdpRI
(Figure 1B; formerly yvaZ- yvbA). In earlier work, we specu-
lated that SdpC exerts its toxic effects by inducing the ex-
pression of sdpRI in target cells (Gonzalez-Pastor et al.,
2003). Our current results, however, lead us to the conclu-
sion that sdpRI is an immunity operon and that its induction
in response to SdpC protects Spo0A-ON cells from the toxic
effects of the protein. Here we present evidence that SdpI is
an immunity protein and that its synthesis is induced by a re-
markably simple signal-transduction system consisting of
SdpC, SdpI, and SdpR. We argue that SdpC is both a toxin
and a ligand; that SdpI is both an immunity protein and a re-
ceptor/signal-transduction protein; and, finally, that SdpR is
an autorepressor. Evidence indicates that induction of the
operon is achieved by membrane sequestration of the
SdpR autorepressor in a manner that depends both on
SdpC and SdpI (Figure 1C). Finally, we show that expression
of sdpRI is blocked in Spo0A-OFF cells by the action of a re-
pressor known as AbrB. Thus, Spo0A-ON cells avoid self-
killing by inducing the synthesis of the SdpI immunity protein
in response to the SdpC toxin/ligand. In contrast, Spo0A-
OFF cells are unable to induce SdpI synthesis due to the ac-
tion of the AbrB repressor and hence succumb to the toxin
(Figure 1A).
RESULTS
SdpI Confers Immunity to the SdpC Toxin
We began our investigation by building an insertion/deletion
mutation of the downstream member of the sdpRI operon,
sdpI (Figure 1B). On solid sporulation medium (DS), the
sdpI mutant grew as small transparent colonies (Figure 2).
Poor growth was dependent upon SdpC because a strain
deleted for both sdpABC and sdpI (created by means of a
single deletion that removed all four genes; Figure 1B) grew
normally and exhibited the accelerated sporulation pheno-
type characteristic of sdpABC mutants (Figure 2). Thus, the
absence of SdpC was epistatic to the absence of SdpI. The
simplest interpretation of these results is that SdpI is an im-
munity protein that protects cells from the toxic effects of
SdpC.
To quantify the effects of SdpC and SdpI and to show that
SdpC acts in an extracellular manner, we performed compe-
tition experiments with mixtures of wild-type and mutant
bacteria. Wild-type cells (that had been tagged with lacZ)
were mixed with an equal number of cells that were mutant
for SdpC alone (as a result of an sdpABC deletion) or both
SdpC and SdpI (as a result of a single deletion removing
Figure 2. SdpI Is Required for Immunity to the SdpC Toxin
Strains were wild-type (PY79) or mutant for SdpC toxin (DsdpABC; strain
EH273), SdpI immunity protein (DsdpI; strain RL2937), or both (DsdpABC
DsdpI; strain EH274). Deletions are described in Figure 1B and the Exper-
imental Procedures. Growth was for 16 hr at 37ºC on solid DS medium
(Harwood and Cutting, 1990).both the sdpABC and sdpRI operons; see Figure 1B), and
the cell mixture was plated on solid DS medium. After 24 hr,
we determined a competitive index, which was the ratio of
the mutant to wild-type (LacZ+) cells divided by the initial
ratio of mutant to wild-type cells. Thus, if a mutant strain
were as fit as the wild-type, the expected ratio would be 1.
We found that a strain that lacked SdpC but could produce
the immunity protein SdpI was not at a competitive disad-
vantage to the wild-type (line 1, Table 1). However, a strain
that was unable to produce both SdpC and SdpI had amark-
edly low index (line 2, Table 1). Moreover, the low competitive
index of the mutant lacking SdpC and SdpI was reversed by
a construct (Figure 1B) in which sdpIwas under the control of
an inducible promoter and was inserted into the chromo-
some at the amyE locus (line 4, Table 1).
Because a strain harboring a deletion (Figure 1B) that re-
moved both sdpABC and sdpRI was at a strong competitive
disadvantage (line 2, Table 1), we conclude that sensitivity to
SdpC did not require SdpR or any other product of the two
operons. Because the strain used in the complementation
experiment (line 4, Table 1) was likewise lacking both op-
erons, we also conclude that SdpI was both necessary
and sufficient to confer immunity to SdpC. In sum, the results
are consistent with the idea that SdpC is an exported, toxic
protein against which SdpI confers immunity.
SdpR Represses the sdpRI Operon
It was known that SdpC, acting extracellularly, activates
transcription of sdpRI, but the transcription factor responsi-
ble for controlling the operon was not identified. We now
present evidence that SdpR, a member of the ArsR family
Table 1. Competition Experiments with LacZ-Tagged
Bacteria
lacZ-Containing
Strains
(Relevant
Genotype)
Test Strain
(Relevant
Genotype)
Competitive
Index
p
Value
wt DsdpABC 1.493 0.283
wt DsdpABC DsdpRI 0.040 0.024
DsdpABC DsdpABC DsdpRI 1.120 0.133
wt DsdpABC DsdpRI
amyE::Phy-spac-sdpI
2.389 0.734
wt DsdpABC DsdpIR
amyE::Phy-spac-
sdpI Q126L
2.049 0.038
The lacZ-containing strains were wt (CDE816) and DsdpABC
(CDE817; see Table S1). The test strains were DsdpABC
(EH273), DsdpABC DsdpRI (EG494), DsdpABC DsdpRI amyE::
Phy-spac-sdpI (CDE235), and DsdpABC DsdpIR amyE::Phy-spac-
sdpIQ126L (CDE541; see Table S1). The competitive index (CI)
was the ratio of the number of LacZ cells (test strain) to
LacZ+ cells arising after growth in solid DS medium divided by
the input ratio of cells from the two strains. Student’s t test
was used for statistical analyses.Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc. 551
of transcription factors, is an autorepressor that is responsi-
ble for inhibiting transcription from sdpRI. Transcription was
monitored using lacZ fused to the promoter region for the
operon, PsdpRI-lacZ. The results of Figure 3 show that a mu-
tant lacking SdpC (as a result of a deletion removing both
sdpABC and sdpI; Figure 1B) was strongly impaired in the
expression of the PsdpRI-lacZ construct. However, a mutant
that was lacking SdpC as well as SdpR (as a result of a dele-
tion removing both the sdpABC and sdpRI operons;
Figure 1B) exhibited a high level of PsdpRI-lacZ expression
(Figure 3). That is, PsdpRI-lacZ was expressed in an SdpC-in-
dependent manner in the absence of SdpR. These results
are consistent with the idea that SdpR is responsible for re-
pressing sdpRI and that the SdpC toxin somehow counter-
acts or inactivates SdpR and thereby induces the operon.
SdpR Binds to the Promoter Region
of the sdpRI Operon
The promoter for the sdpRI operon is contained within a 447
bp DNA segment spanning the region between sdpR and
the gene immediately upstream (Gonzalez-Pastor et al.,
2003). To localize the promoter precisely, we carried out
primer extension analysis to map the 50 end of RNA originat-
ing from the operon (Figure 4A). The results of Figure 4A
show that upstream of the 50 terminus (putative start site)
were sequences that exhibited a three-out-of-six match
(TTGttt) to the canonical35 sequence (TTGACA) and a per-
fect match (TATAAT) to the canonical10 sequence for pro-
moters recognized by sA-containing RNA polymerase.
To determine whether SdpR interacts with the promoter
region, we performed electrophoretic mobility shift assays
using purified SdpR that had been tagged at its C terminus
with six histidine residues (SdpR-His6) and DNA correspond-
ing to a 418 bp DNA segment containing the sdpRI promoter
(PsdpRI). As a negative control, we used a similarly sized DNA
from within the open-reading frame for sdpC. The results of
Figure 4B show that SdpR-His6 retarded the electrophoretic
mobility of the PsdpRI–containing DNA but not that of the con-
trol DNA. The existence of two retarded species suggests
that SdpR-His6 binds to a minimum of two sites in the pro-
moter region.
Finally, we carried out DNase I footprinting to localize the
binding sites for SdpR. A 108 bp DNA probe corresponding
to the region upstream and inclusive of the predicted start
codon for sdpR was incubated with various concentrations
of SdpR-His6 and then treated with DNase I. Upon subject-
ing the products of enzyme treatment to gel electrophoresis,
we observed two regions of protection: a 7 bp region located
immediately upstream of the transcriptional start site (posi-
tion +1) and a 25 bp region located between positions +5
and +29 (Figure 4A). Contained within the two regions were
four similar direct repeat sequences centered at positions -4
(50-TGAAAAT-30), +13 (50-TACAAAT-30), +21 (50-TCTAA
AT-30), and +29 (50-TCTAAAT-30). Other members of the
ArsR family are known to bind to DNA as homodimers (Bu-
senlehner et al., 2003), and the results of our electrophoretic
mobility shift and DNase I footprinting assays suggest that
SdpR binds to the sdpRI promoter region as two dimeric552 Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc.complexes. The extensive overlap of the SdpR binding sites
with PsdpRI suggests that the autorepressor blocks transcrip-
tion by interfering with the binding of RNA polymerase to the
promoter.
The SdpI Immunity Protein Is Required
for the Transcriptional Response to SdpC
How does extracellular SdpC toxin relieve SdpR-mediated
repression of the sdpRI operon? A clue came from the ob-
servation that a mutant lacking the SdpI immunity protein
was blocked in the expression of the sdpRI operon (see
Figure S1 in the Supplemental Data available with this article
online). Two possible explanations for this observation were
that SdpI is required for the production of SdpC or that SdpI
is involved in the transcriptional response to the toxin.
To investigate the possibility that SdpI is required for SdpC
production, we carried out a series of extracellular comple-
mentation experiments each involving three parallel streaks
of cells on solid sporulationmedium in which the two flanking
streaks were from a reporter strain that lacked the sdpABC
operon and contained the PsdpRI-lacZ fusion construct.
The results of Figure 5 (top set of streaks) show that induc-
tion of PsdpRI-lacZ was readily detected when the streak in
the middle (the producer strain) was generated with wild-
type cells or with cells of an sdpI mutant. In contrast and
as a control, no induction was detected when the middle
streak was generated with cells of an sdpABC mutant. We
conclude that SdpI is not required for the production or ex-
port of the SdpC toxin.
Next we asked whether SdpI was required for the re-
sponse to SdpC by creating a PsdpRI-lacZ-bearing reporter
Figure 3. SdpR Is Required for Repression of the sdpRI
Immunity Operon
All strains contained PsdpRI-lacZ and were otherwise wild-type (wt; strain
CDE304) or mutant for the SdpC toxin and the SdpI immunity protein
(DsdpABC DsdpI; strain CDE569), the SdpR autorepressor (DsdpR;
strain CDE362), or all three (DsdpABC DsdpIR; strain CDE312). Growth
was for 16 hr at 37ºC on solid LB medium (Harwood and Cutting,
1990) containing X-Gal.
Figure 4. Identification of SdpR Binding Sites within the
sdpRI Promoter Region
(A) Identification of the sdpRI transcriptional start site and SdpR binding
sites within the PsdpRI promoter region. Lane 1 in (A) shows the results
of a primer-extension assay performed to determine the transcription start
site of the sdpRI promoter. RNA isolated from early-stationary-phase
B. subtilis cells was used as a template for extension of the radiolabeled
primer ECH253. The same primer was also used to generate dideoxy-strain that lacked both sdpABC and sdpI. When this reporter
strain (flanking streaks) was tested against the indicated
producer strains (middle streaks), little or no expression of
PsdpRI-lacZ was detected (Figure 5, center set of streaks).
(Since killing requires higher concentrations of toxin than in-
duction does, the gaps between the streaks allowed induc-
tion to be studied without extensive killing of the cells lacking
SdpI [left- and right-hand images].)
Finally, we created a PsdpRI-lacZ-bearing reporter strain
that lacked both sdpABC and sdpI but additionally harbored
an inducible copy of sdpI that had been inserted into the
chromosome at the amyE locus (amyE::Phy-spac-sdpI). The
results of Figure 5 (bottom set of streaks) show that the pres-
ence of the amyE::Phy-spac-sdpI construct restored the
sequencing ladders that were terminated with ddATP (lane 2), ddTTP
(lane 3), ddGTP (lane 4), and ddCTP (lane 5). Lanes 6–12 show the results
of a DNase I protection assay performed with radiolabeled DNA and in-
creasing concentrations of SdpR-His6: 0 nM (lanes 6 and 12), 5 nM
(lane 7), 50 nM (lane 8), 100 nM (lane 9), 300 nM (lane 10), and 500 nM
(lane 11). The annotated DNA sequence shown to the right of (A) is
complementary to the sequence shown in lanes 2–5. The putative 10
and 35 promoter elements are marked with solid black boxes. Pre-
dicted recognition sequences for SdpR-His6 are denoted by black arrows
and a number indicating the position of the center of the sequence relative
to the transcription start site.
(B) Electrophoretic mobility shift assays shown in (A) contain 32P-labeled
DNA corresponding to a DNA fragment internal to the sdpC open reading
frame or to DNA contained within the sdpR promoter region. Increasing
concentrations of purified SdpR-His6 ranging from 0 nM to 150 nM
were included in the indicated reactions.
Figure 5. The SdpI Immunity Protein Is Required for the In-
duction of PsdpRI-lacZ in Response to Extracellular SdpC
The central streaks were wild-type (wt; PY79) or mutant for sdpABC
(SdpC; EH273) or mutant for sdpI (SdpI; RL2937). (Note that the cen-
tral streaks of SdpC-producing cells in the right-hand columnwere under-
going lysis due to the absence of SdpI.) The flanking streaks were strains
that were mutant for sdpABC (CDE568), mutant for sdpABC and sdpI
(CDE569), or mutant for sdpABC and sdpI and containing the comple-
mentation construct amyE::Phy-spac-sdpI
+ (CDE571). All of the flanking
strains contained the reporter PsdpRI-lacZ. Growth was at 37ºC for 24 hr
on solid DS medium containing X-Gal and IPTG.Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc. 553
capacity of the reporter strain to respond to SdpC. In toto,
the results indicate that SdpI is involved in the transcriptional
response to the toxin.
SdpI Is Both an Immunity Protein
and a Signal-Transduction Protein
SdpI is predicted to be an integral membrane protein with
multiple membrane-spanning segments (Figure 1C). Two
models for how it could mediate the transcriptional response
to SdpC are that (1) SdpI is a transporter that pumps SdpC
into the cell where the toxin directly or indirectly antagonizes
the SdpR autorepressor and (2) SdpI is a signal-transduction
protein that acts as a receptor for SdpC on the outside sur-
face of the cell, transducing a signal that triggers events in-
side the cell that inactivate the SdpR autorepressor. To dis-
tinguish between these models, we sought mutants of SdpI
that would constitutively activate transcription of the sdpRI
operon in the absence of SdpC. We reasoned that if SdpI
is a receptor/signal-transduction protein, then it should be
possible to obtain mutants that lock the protein in an acti-
vated state in the absence of the SdpC ligand, but that if
SdpI acts by transporting SdpC into the cell where it antag-
onizes the SdpR autorepressor, then it should not be possi-
ble to obtain such mutants.
Accordingly, we performed localized mutagenesis on sdpI
and screened for mutants that allowed PsdpRI-lacZ to be
expressed in the absence of SdpC. We readily obtained sev-
eral amino acid substitution mutants of SdpI that partially
bypassed the requirement for SdpC in the expression of
PsdpRI-lacZ (e.g., SdpI
F78I; Figure S2). Most of the substitu-
tions were found to cluster in the first three, putative trans-
membrane segments of SdpI (Figure 1D). The simplest inter-
pretation of these results is that that SdpI normally acts
as a receptor for SdpC and that SdpI responds to the SdpC
ligand by directly or indirectly inhibiting the repressor activity
of SdpR.
Mutants of SdpI Blocked in Signal Transduction
We also sought mutants of SdpI that retained the capacity to
confer immunity but failed to induce transcription of sdpRI in
response to SdpC. To do this, we performed localized muta-
genesis on an IPTG-inducible copy of sdpI and screened for
mutants that were unable to induce expression of PsdpRI-
lacZ. Mutants that failed to induce PsdpRI-lacZ were then
subjected to a secondary screen by streaking on solid DS
medium to identify those that maintained the capacity to
protect against killing by SdpC. We obtained two such mu-
tants, one of which, the amino acid substitution mutant
SdpIQ126L (Figure 1D), was characterized further. Figure S1
shows that an inducible copy of the mutant gene (sdpIQ126L)
was unable to respond to extracellular SdpC in inducing the
expression of PsdpRI-lacZ. The sdpI
Q126L mutation was re-
cessive as evidenced by the fact that a strain containing
both sdpI and sdpIQ126L was fully capable of inducing ex-
pression of PsdpRI-lacZ (data not shown). To quantify the ca-
pacity of resistance of SdpIQ126L to confer immunity to SdpC,
we created a strain that contained an inducible copy of
sdpIQ126L and that lacked both the sdpABC and the sdpRI554 Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc.operons. Next, this SdpIQ126L-producing strain was mixed
with an equal number of wild-type cells. The results of Table 1
show that the SdpIQ126L-producing strain was not at a com-
petitive disadvantage to the SdpC-producing, wild-type cells.
In toto, these results indicate that SdpIQ126L had retained
the capacity to confer immunity to SdpC but was unable to
induce a transcriptional response in the presence of the
toxin. In effect, SdpIQ126L exhibited the opposite phenotype
of SdpIF78I (above), which was capable of stimulating tran-
scription from the sdpRI promoter in the absence of SdpC.
On the basis of the phenotypes of both kinds of mutants,
we conclude that SdpI has two separable functions: it pro-
tects cells against the toxic effects of SdpC, and it responds
to SdpC by inducing the sdpRI operon and thus the synthe-
sis of additional immunity and repressor protein.
SdpR-GFP Is Sequestered to the Membrane
in an SdpC- and SdpI-Dependent Manner
How do SdpI and SdpC prevent repression by SdpR? The
answer emerged from experiments in which we visualized
the subcellular localization of SdpR using a functional fusion
of the autorepressor to the green fluorescent protein (GFP).
Production of the SdpR-GFP fusion was placed under the
control of the normal promoter for the sdpRI operon. The re-
sults of Figure 6A show that, in otherwise wild-type cells, the
fusion protein was localized to the cytoplasmic membrane
(left-hand image). In SdpC mutant cells, in contrast, only
a faint signal could be detected (middle image), which
upon image enhancement was seen as being diffusely dis-
tributed throughout the cytoplasm (right-hand image). The
simplest interpretation of these results is that SdpC is re-
sponsible for causing SdpR-GFP to become sequestered
at the membrane. In the absence of SdpC, SdpR-GFP
was not sequestered and hence was free to repress tran-
scription. Because production of SdpR-GFP was under
the control of the sdpRI promoter, this repression would
have resulted in a low level of synthesis of the fusion protein,
accounting for the faint signal observed in the mutant cells.
To uncouple the synthesis of both SdpR-GFP and SdpI
from autoregulation, we constructed a strain in which the
expression of sdpR-gfp was under the control of a xylose-
inducible promoter and the only copy of sdpI was under
the control of an IPTG-inducible promoter. The results of
Figure 6B show that SdpR-GFP was localized to the mem-
brane of cells of this strain that had been treated with xylose
and IPTG. In inducer-treated cells of an otherwise iden-
tical strain that was mutant for SdpC, SdpR-GFP was uni-
formly distributed in the cytoplasm (Figure 6C, left-hand
image).
To investigate whether membrane sequestration was de-
pendent upon SdpI, we created a strain in which SdpR-GFP
was under the control of the xylose-inducible promoter and
that was mutant for SdpI and wild-type for SdpC. Once
again, SdpR-GFP was found to be diffusely localized
throughout the cytoplasm (Figure 6B, middle image). We
conclude that membrane sequestration depends both on
the toxin/ligand SdpC and the immunity/signal-transduction
protein SdpI.
Based on these results, we predicted that the constitu-
tively active mutants of SdpI (e.g., SdpIF78I), which are capa-
ble of activating PsdpRI-lacZ in the absence of SdpC, would
Figure 6. SdpI and SdpC Sequester SdpR-GFP to the Mem-
brane
(A) Shown are cells in which a functional SdpR-GFP fusion was produced
under the control of its native sdpRI promoter (PsdpRI). The top panel
shows, from left to right, fluorescent images of SdpC+ cells (strain
EH390), cells mutant for SdpC (DsdpC; EH391), and an artificially en-
hanced micrograph of the middle image.
(B) Shown are cells in which SdpR-GFP was produced under the control
of a xylose-inducible promoter and that were producing wild-type SdpI
(DsdpI amyE::Phy-spac-sdpI; EH398), were lacking SdpI (DsdpI; EH393),
or were producing the SdpIQ126L mutant protein (DsdpI amyE::Phy-spac-
sdpIQ126L; CDE622).
(C) Shown are cells in which SdpR-GFP was produced under the control
of a xylose-inducible promoter and that were lacking SdpC. Additionally,
the cells in the image on the left were producing wild-type SdpI (DsdpABC
DsdpI amyE::Phy-spac-sdpI; EH394), and those on the right were produc-
ing the SdpIF78I mutant protein (DsdpABC DsdpI amyE::Phy-spac-sdpI
F78I;
EH395).
(D) Shown is an immunoblot of proteins from cells grown on solid DS me-
dium. T, S, and P represent total, soluble, and pellet fractions, respec-
tively. All four strains produced SdpR-GFP under the control of xylose.
The phenotypes of the strains with respect to SdpI and SdpC are indi-
cated at the top of the figure. The strains used for this experiment (from
left to right on the gel: EH394, EH395, EH404, and EH398) are as
described above, with the exception of EH404 (thrC::Pxyl-sdpR-gfp
sdpABCI::kan). The immunoblot was probed with antibodies against
the cytoplasmic protein sA and GFP.sequester SdpR-GFP to the membrane in an SdpC-inde-
pendent manner. Conversely, mutants of SdpI that provide
immunity against SdpC but fail to activate PsdpRI-lacZ in its
presence (e.g., SdpIQ126L) would be blocked in membrane
sequestration. To test these predictions, we created con-
structs in which the sdpIF78I and sdpIQ126L alleles were under
the control of the IPTG-inducible promoter. Figure 6C (right-
hand panel) shows that SdpR-GFP was localized to the
membrane in cells of an SdpIF78I-producing strain that was
mutant for SdpC. Conversely, Figure 6B (right-hand panel)
shows that SdpR-GFP was diffusely distributed in the cyto-
plasm of an SdpIQ126L-producing strain that was SdpC+.
As a biochemical test of the idea that the SdpR autore-
pressor is sequestered in an SdpI-dependent manner, we
carried out subcellular fractionation experiments in which
SdpR-GFP-producing cells were disrupted and soluble pro-
teins were separated from insoluble material (the pellet) by
centrifugation (Figure 6D). We monitored the presence of
SdpR-GFP in the soluble and pellet fractions with material
from cells of a strain engineered to produce the constitutively
active mutant form of the immunity protein SdpIF78I and with
material from cells of a strain of an SdpI null mutant. SdpR-
GFP was detected by immunoblot analysis using anti-GFP
antibodies. Strikingly, SdpR-GFP was present in the pellet
fraction from cells of the constitutively active SdpIF78I mutant,
but little or no SdpR-GFPwas in the pellet fraction of the SdpI
null mutant. As a control, immunoblot analysis with anti-
bodies directed against the RNA polymerase subunit sA
showed that the presence of this cytoplasmic protein was re-
stricted to the soluble fraction. The results of Figure 6D also
show that SdpR-GFP was detected in the pellet fraction of
cells producing wild-type SdpI and that the level of the signal
was stronger in the presence of SdpC than in its absence.
Finally, an experiment with cells producing the mutant form
(SdpIQ126L) of the signal-transduction protein that was un-
able to sequester SdpR-GFP revealed little or no SdpR-
GFP in the membrane-containing pellet fraction (data not
shown).
sdpRI Is under the Indirect Control of Spo0A
A final question was why cells that have not activated Spo0A
are killed by the SdpC toxin. That is, why are they unable to
induce the immunity operon? A simple hypothesis was that
the sdpRI operon (like the sdpABC operon) is under Spo0A
control, thereby ensuring that only cells that have entered
the pathway to sporulate will be able to produce the SdpI im-
munity protein. In confirmation of this hypothesis, the results
of Figure 7 show that, in the absence of SdpC and SdpR,
PsdpRI-lacZ was induced in liquid sporulation medium at
the start of sporulation and that this induction was depen-
dent upon Spo0A. The dependence on Spo0A was, how-
ever, indirect, as PsdpRI-lacZ was expressed at a high level
during both growth and sporulation in cells of an AbrB mu-
tant and in cells doubly mutant for Spo0A and AbrB (Figure 7
and Figure S3). The gene for AbrB is known to be under the
direct negative control of Spo0A, and AbrB is known to be
a repressor of certain genes that are switched on at the onset
of sporulation (Strauch et al., 1989, 1990).Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc. 555
DISCUSSION
A Three-Protein Signal-Transduction System
We have elucidated a remarkably simple signal-transduction
system that is composed of a ligand, SdpC; a receptor/
signal-transduction protein, SdpI; and an autorepressor,
SdpR. We propose that the ligand SdpC interacts at the
membrane with SdpI, an inferred polytopic membrane pro-
tein, to induce a conformational change in the receptor/
signal-transduction protein. This conformational change, in
turn, allows SdpI to bind SdpR and thereby capture the
autorepressor at, and on the cytoplasmic face of, the mem-
brane (Figure 1C). Sequestration in a complex with SdpI
at the membrane directly or indirectly prevents SdpR from
binding at the promoter for the sdpRI operon, thereby reliev-
ing repression and stimulating the synthesis of SdpR and
SdpI. At the heart of our model is a heteromeric complex
composed of SdpC, SdpI, and SdpR (Figure 1C), but we
do not know whether these are the only proteins in the
complex and whether SdpI directly contacts SdpC and
SdpR.
Underscoring the economy of this simple system, two of
its components have a second function. Thus, SdpC is the
ligand that induces sdpRI and also a toxin that kills target
cells during cannibalism. The mechanism by which this 63
residue peptide acts is unclear, but a possible clue is the
presence of a putative hydrophobic a helix that resembles
a transmembrane segment. It is therefore attractive to imag-
ine that SdpC acts by inserting itself into the membrane of
Figure 7. The sdpRI Operon Is under the Indirect Control of
Spo0A via the AbrB Repressor
All strains harbored amyE::PsdpRI-lacZ and carried a single deletion of
sdpABC and sdpIR (Figure 1B). The strains were wild-type for spo0A
and abrB (EG504) (closed circles), mutant for spo0A (EH253) (closed
boxes), mutant for abrB (EH254) (closed diamonds), or mutant for both
spo0A and abrB (EH255) (open circles). Cells were grown in liquid DS
medium to induce sporulation; the initiation of sporulation is hour 0. The
b-galactosidase activity units were calculated as Miller units (Harwood
and Cutting, 1990; Miller, 1972).556 Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc.target cells where it could, for example, cause the mem-
brane to become leaky. Also, and in keeping with the idea
that SdpC is a toxin, the peptide’s amino acid sequence
weakly resembles that of certain antimicrobial peptides of
insects known as defensins (Lehane et al., 1997).
SdpI also does double duty in that it is both a signal-trans-
duction protein and an immunity protein. That SdpI has two
distinct functions is supported by the isolation of mutants
that separate one function from the other. Thus, the mutant
protein SdpIQ126L was capable of conferring immunity to
SdpC but failed to trigger induction of the sdpRI immunity
operon in the presence of the toxin/ligand. Conversely, mu-
tants like SdpIF78I were capable of causing membrane se-
questration of the SdpR autorepressor and transcription of
sdpRI in the absence of SdpC. The simplest interpretation
of our results is that SdpC forms a complex with SdpI in
the membrane and that this SdpC-SdpI complex serves
both to neutralize the toxic effects of SdpC and to induce
the expression of sdpRI.
The SdpR autorepressor belongs to the ArsR/SmtB family
of repressors, whose prototypical member, ArsR, inhibits
the transcription of genes involved in resistance to arsenate
(Busenlehner et al., 2003). Expression of these genes is in-
duced by arsenate, which acts by binding to a metal binding
domain in the protein. In contrast to ArsR and other family
members, SdpR lacks the conserved amino acids found
in metal-responsive members of the family (Busenlehner
et al., 2003). Instead, our evidence indicates that induction
of its target, sdpRI, is achieved by sequestration of the auto-
repressor in a complex with SdpI.
Repressor Regulation by Membrane Sequestration
Regulation of a bacterial repressor by membrane sequestra-
tion is an unusual mode of gene control in bacteria, but two
precedents are known. One is PutA, a repressor of genes in-
volved in proline uptake and utilization in Salmonella typhi-
murium (Ostrovsky de Spicer et al., 1991). In the absence
of proline, PutA binds to and represses putA and putP, which
are required for utilization and transport of proline, respec-
tively (Hahn et al., 1988). In the presence of proline, however,
PutA redistributes itself to the membrane, losing its ability to
bind to DNA (Ostrovsky de Spicer and Maloy, 1993; Ostrov-
sky de Spicer et al., 1991). Genetic and biochemical evi-
dence indicate that DNA binding and membrane localization
are mutually exclusive (Muro-Pastor et al., 1997; Ostrovsky
de Spicer andMaloy, 1993). A second is the E. coli repressor
Mlc, which is sequestered at the membrane by the glucose
transporter IICB when it is phosphorylated and actively im-
porting glucose (Lee et al., 2000; Tanaka et al., 2000). Mlc
is unable to repress target genes in a transporter-indepen-
dent manner when it is artificially tethered to the membrane
(Bohm and Boos, 2004; Tanaka et al., 2004).
Thus, in these examples, simple sequestration at the
membrane is evidently sufficient to block repressor activity.
It will be interesting to determine whether this is also the
case for SdpR or whether the interaction of SdpR with
SdpI contributes to preventing the autorepressor from block-
ing the sdpRI promoter.
Just-in-Time Regulation
We view the SdpC-SdpI-SdpR system as a just-in-time reg-
ulatory circuit. In the absence of the toxin/ligand SdpC, the
sdpRI operon is held at low (basal) level of expression by
the autorepressor SdpR, and hence only a small number of
SdpI molecules are produced (left side of Figure 1C). When
SdpC appears in the medium, it binds to the SdpI signal-
transduction protein, triggering sequestration of SdpR (right
side of Figure 1C). This derepresses the operon, leading to
the synthesis of more SdpI molecules and more SdpR mole-
cules. As long as sufficient SdpC is present to bind to all of the
SdpI molecules, newly synthesized SdpR molecules are se-
questered at the membrane, leading to continued high-level
transcription. However, when excess, unligated SdpI mole-
cules start to accumulate, free SdpR molecules begin to ac-
cumulate in the cytoplasm and inhibit further transcription.
Thus, just-in-time regulation explains how SdpC-producing
cells make only asmuch SdpI immunity protein as they need.
The Immunity Operon Is Subject to an AND Gate
Just-in-time regulation leaves unanswered the question of
why during cannibalism cells that have not activated
Spo0A are killed by the toxin. The discovery that the sdpRI
operon is also under the indirect control of Spo0A via the re-
pressor AbrB provides a simple answer. Thus, in cells that
have not activated Spo0A, the operon is held inactive by
the AbrB repressor. Conversely, in cells that have activated
the master regulator for sporulation, Spo0A represses the
gene for AbrB, thereby releasing the operon from repression.
The immunity operon is therefore subject to an AND Gate in
which expression requires both the presence of the toxin/
ligand SdpC and the absence of the repressor AbrB.
We have elucidated an intricate series of regulatory inter-
actions that explain how and whether cells respond to the
cannibalism toxin SdpC. Cells that have activated Spo0A
switch on both the operon (sdpABC) that is responsible for
the production and export of the SdpC as well as the immu-
nity operon (sdpRI) that protects the producing cells from the
toxin. Induction of the immunity operon is subject to two con-
trol mechanisms, which together ensure that the operon is
expressed in toxin-producing cells and not in sibling cells
that have not activated Spo0A (Figure 1A). One control
mechanism is a signal-transduction pathway that induces
synthesis of the SdpI immunity protein in a just-in-time man-
ner via the action of the autorepressor SdpR. The other con-
trol mechanism involves the repressor AbrB, which blocks
the induction of the immunity operon in cells that have not
activated Spo0A even when those cells are challenged
with the SdpC toxin/ligand. Thus, whether or not a cell acti-
vates Spo0A in response to conditions of nutrient limitation
has a profound influence on whether that cell will kill its non-
sporulating siblings or whether it will itself be cannibalized.
EXPERIMENTAL PROCEDURES
Strain Construction
Strains are otherwise isogenic derivatives of the wild-type B. subtilis strain
PY79 (Youngman et al., 1984) and are listed in Table S1. B. subtilis com-petent cells were prepared by the one-step method previously described
(Wilson and Bott, 1968). The PsdpRI-lacZ reporter at thrCwas constructed
by PCR amplifying the PsdpRI region using CDEP128 and CDEP129. The
resulting PCR product was digested with EcoRI and BamHI and cloned
into pDG1663 (Guerout-Fleury et al., 1996) digested with the same sites
to create pCE111. The sdpR-gfp fusion under the control of the PsdpRI
promoter (pEH210) was constructed by PCR amplifying PsdpRI-sdpR
using CDEP128 and ECH302. The gfp gene was PCR amplified using
OMF10 and OMF11, and the resulting products were digested with EcoRI
and XbaI (PsdpRI-sdpR) and XbaI and BamHI (gfp). The digested products
were then cloned by three-way ligation into pDG1731, which had been
digested with EcoRI and BamHI, to create pEH210. A plasmid containing
a xylose-inducible promoter that could be integrated into the thrC locus
(pEH211) was created by cloning the HindIII-EcoRI fragment from
pDR150 (gift of David Rudner) into pDG1664 (Guerout-Fleury et al.,
1996), which had also been digested with HindIII and EcoRI. The sdpR-
gfp fusion under the control of a xylose-inducible promoter (pEH212)
was constructed by PCR amplifying sdpR-gfp from pEH210 using
ECH301 and OMF11. The resulting products were digested with HindIII
and BamHI. The digested products were then cloned into pEH211, which
had also been digested with HindIII and BamHI to create pEH212.
Deletion Mutations
We used the long-flanking homology polymerase chain reaction (LFH-
PCR) technique for creating deletion mutations (Wach, 1996) using the
primers listed in Table S2. The deletion/insertion sdpABC::kan was con-
structed by PCR amplifying the 50-flanking region of sdpABC with
ECH278 and ECH279, while the 30-flanking region was amplified using
ECH280 and ECH281. The deletion/insertion sdpABCI::kan was con-
structed by PCR amplifying the 50-flanking region of sdpABCI using
ECH278 and ECH279, while the 30-flanking region was amplified using
ECH288 and ECH289. The deletion/insertion sdpI::tet was constructed
by PCR amplifying the 50-flanking region of sdpI with EG_SDPI-1 and
EG_SDPI-2, while the 30-flanking region was amplified using EG_SDPI-3
and EG_SDPI-4. The resulting PCR products were then used as primers
to amplify the kanamycin-resistance cassette from the plasmid pDG780
or the tetracycline-resistance cassette from the plasmid pDG1515 (Guer-
out-Fleury et al., 1995) as previously described (Wach, 1996). The PCR
products were then transformed into PY79 as previously described.
The sdpR::tet mutation was similarly constructed. It is insertion of the
tetracycline-resistance cassette from pDG1515 that replaces the entire
open reading frame of sdpR. The mutants were confirmed by PCR.
Medium Supplements
Antibiotics were used at the following concentrations: chloramphenicol,
5 mg/ml; erythromycin plus lincomycin, 1 mg/ml and 25 mg/ml; kanamycin,
5 mg/ml; spectinomycin, 100 mg/ml; tetracycline, 10 mg/ml; ampicillin,
100 mg/ml. The b-galactosidase chromogenic indicator 5-bromo-4-
chloro-3-indolyl b-D-galactopyranoside (X-Gal) was used at a concentra-
tion of 100 mg/ml. Xylose was used at a final concentration of 0.1% (w/v).
IPTG was used at a final concentration of 1 mM.
Localized Mutagenesis of sdpI
Localized mutagenesis was performed by PCR using primers CDEP133
and CDEP134 to amplify the inducible copy of sdpI+ integrated at amyE
CDE254 using Expand polymerase according to the manufacturer’s in-
structions. The resulting PCRproduct was concentrated and transformed
into the strain CDE569, which contains a deletion of sdpABCI and the
PsdpRI-lacZ reporter integrated at thrC. Mutants that increased expression
of the PsdpRI-lacZ reporter were then backcrossed to confirm that the
mutation was linked to sdpI. These mutants were then sequenced by
PCR amplifying the sdpI mutant alleles using primers CDEP133 and
CDEP134. The resulting PCR products were then sequenced using the
ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit (Per-
kinElmer) and either primer CDEP137 or CDEP138 according to the man-
ufacturer’s instructions.Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc. 557
Competition Assays
Solid Difco sporulation (DS) medium was inoculated with approximately
5  108 cells per ml of a 1:1 mixture of a wild-type strain marked with lacZ
(amyE::Pcons-lacZ) and mutant strains. The colony-forming units and rel-
ative percentage represented by each strain were determined by direct
plating of the inocula. After 24 hr, the cells were collected with 5 ml liquid
DS medium, and serial dilutions were plated on LB + X-Gal medium to
determine the ratio of mutant to wild-type. The competitive index (CI)
was calculated as (mutant recovered/wild-type recovered)/(mutant
inoculated/wild-type inoculated). Student’s t test was used for statistical
analyses.
Primer Extension
Total RNA was prepared as previously described from PY79 cells grown
in DS medium until 1 hr past the start of stationary phase (Britton et al.,
2002). The 50 end of a DNA oligonucleotide primer (ECH253) was radio-
actively labeled using polynucleotide kinase (PNK) and 40 mCi of
[g-32P]ATP (NEG002A, New England Nuclear). This end-labeled primer
was annealed to 20 mg of RNA in the presence of 1 first-strand buffer
(InvitrogenSuperScript First-StrandSynthesis System for RT-PCR) in a to-
tal reaction volume of 10 ml. The reaction mixture was incubated at 95ºC
for 1 min, at 70ºC for 2 min, and finally on ice for 15 min. The extension
reaction was performed using 5 ml of the above annealing reaction,
10 mMDTT, 1 mM dNTPs (250 mM for each dNTP), 1 first-strand buffer,
and 10 units of SuperScript II RNase H Reverse Transcriptase. The re-
action mixture was incubated for 45 min at 44ºC, after which 5 ml of form-
amide loading buffer (80% deionized formamide, 10 mM EDTA, 0.001%
[w/v] xylene cyanol FF, 0.001% [w/v] bromophenol blue) was added to
stop the reaction.
Purification of SdpR-His6
The entire sdpR ORF except its stop codon was amplified from B. subtilis
PY79 chromosomal DNA by PCR using primers ECH218 and ECH219.
This DNA fragment was cloned into the NdeI and XhoI sites of pET21b
(Invitrogen) to create pEH201. pEH201 was subsequently transformed
into E. coli BL21(DE3) RIL-CodonPlus cells. This strain carries a plasmid
that contains genes coding for three rare tRNAs recognizing arginine,
isoleucine, and leucine to allow for optimal expression of heterologous
proteins.
One liter of culturewasgrown inLBbroth supplementedwith100mg/ml1
ampicillin at 30ºC until the OD600 reached 0.5. At this point, IPTG was
added to a final concentration of 1 mM, and the culture was allowed to
grow for an additional 3 hr at 30ºC. The cells were then harvested and re-
suspended in 40 ml of lysis/binding buffer (20 mM Tris-HCl [pH 8.0], 20%
[v/v] glycerol, 5 mM imidazole) and lysed by sonication. The lysate was
centrifuged at 30,000 g to separate cellular debris from solublematerial.
One milliliter of Ni2+-NTA agarose beads (QIAGEN) was added to the
cleared lysate, which was subsequently rotated for 1 hr at 4ºC. The beads
were then separated from the liquid by centrifugation at 5000  g and
resuspended in 2 ml of binding buffer. The beads were then washed
with 2 ml of binding buffer five times (10 ml total). The bound protein
was eluted from the beads with 2 ml of elution buffer (20 mM Tris [pH
8.0], 20% glycerol, 400 mM imidazole), and the eluate was dialyzed
against 1 liter of TGE buffer (50 mM Tris [pH 8.0], 50% [v/v] glycerol,
5 mM EDTA) overnight at 4ºC. The dialyzed protein was aliquoted and
stored at 80ºC.
Electrophoretic Mobility Shift Assay
DNAprobes corresponding to the sdpRI promoter (PsdpRI) and to a portion
of the sdpC ORF were generated by PCR using B. subtilis PY79 chromo-
somal DNA and primer pairs ECH245/ECH246 (PsdpRI) and ECH239/
ECH240 (sdpC ORF). These probes were gel purified and subsequently
50-end labeled using PNK and 10 mCi of [g-32P]ATP (NEG002A, New En-
gland Nuclear). DNA binding reactions were conducted in a total volume
of 30 ml containing 10mM Tris (pH 8.0), 50 mMNaCl, 1 mM EDTA, 5% (v/
v) glycerol, 1 mM DTT, 50 mg ml1 bovine serum albumin (BSA), 25 mg/
ml1 polydeoxyinosinicdeoxycytidylic acid (poly dI-dC), 2000 cpm/ml1558 Cell 124, 549–559, February 10, 2006 ª2006 Elsevier Inc.radioactive probe, and various amounts of SdpR-His6. The reactions
were incubated for 20 min at room temperature. Ten microliters of each
reaction was loaded onto a 6% polyacrylamide TBE gel and electrophor-
esed for 1 hr at 200V. Radioactive species were detected by autoradiog-
raphy after exposure overnight to a Fujifilm Phosphoimaging Plate.
DNase I Footprint Assay
The 50 end of the DNA oligonucleotide primer ECH253 was radioactively
labeled using PNK and 70 mCi of [g-32P]ATP. A DNA fragment cor-
responding to the sdpRI promoter region (PsdpRI) was generated by
PCR using B. subtilis PY79 chromosomal DNA, ECH254, and radiola-
beled ECH253. This PCR product was subsequently gel purified, and
the amount of incorporated radioactivity was quantified with a scintillation
counter. DNA binding reactions were conducted in 100 ml of footprinting
buffer (20 mM Tris [pH 8.0], 5 mM MgCl2, 5 mM CaCl2, 100 mM DTT,
100 mM EDTA, 50 mg/ml1 BSA, 5 mg/ml1 poly dI-dC) with 30,000 cpm
of radiolabeled PCR probe and various concentrations of SdpR-His6.
After a 15 min incubation period at room temperature, 0.04 units of DN-
ase I was added to each DNA binding reaction. The digestion was allowed
to proceed for 30 s at room temperature before 25 ml of stop solution
(1.5 M sodium acetate [pH 5.3], 20 mM EDTA, 400 mg/ml1 glycogen)
was added to terminate the reaction. The reaction products were then
precipitated with ethanol and resuspended in 8 ml of formamide running
buffer. Four microliters of each sample was loaded onto an 8% sequenc-
ing gel (SequaGel Sequencing System, National Diagnostics) and sub-
jected to electrophoresis for 2 hr at 35 mW. Radioactive species were
detected by autoradiography after exposure overnight to a Fujifilm Phos-
phoimaging Plate.
Microscopy
Cells growing on DS agar were suspended in 1 PBS containing the
membrane stain FM4-64 (Molecular Probes) at a concentration of 1 mg/
ml. When necessary, IPTG and xylose were added to the media at final
concentrations of 1 mM and 0.1% (w/v), respectively. The concentrated
cell suspension (3 ml) was placed on amicroscope slide. Cells were immo-
bilized using a freshly prepared poly-L-lysine-treated coverslip. The
equipment used and the capture and analysis of the images were done
as previously described (Fujita and Losick, 2002).
Immunoblot Analysis of SdpR-GFP Localization
Overnight cultures were diluted to an OD600 of 0.5 and plated onto solid
DS media supplemented with 1 mM IPTG and 0.1% (w/v) xylose. These
plates were incubated for 4.5 hr at 37ºC, after which time the confluent
‘‘lawns’’ of bacteria were harvested. The cells were then protoplasted in
10 mM KH2PO4/K2HPO4 (pH 6.8) containing 0.5 M sucrose and
20mMMgCl2 essentially as described (Harwood and Cutting, 1990). Pro-
toplasts were lysed by suspension in ice-cold 10 mM KH2PO4/K2HPO4
(pH 6.8) containing 250 mM EDTA (pH 8.0) followed by sonication. Solu-
ble material was separated from the insoluble material by ultracentrifuga-
tion at 100,000  g for 1 hr at 4ºC. After electroblotting, proteins were
detected by incubating in a 1:10,000 dilution of either a-sA or a-GFP an-
tibodies followed by incubation in a 1:10,000 dilution of goat anti-rabbit
IgG (H+L)-HRP conjugate from Bio-Rad.
Supplemental Data
Supplemental Data include Supplemental References, two tables, and
three figures and can be found with this article online at http://www.
cell.com/cgi/content/full/124/3/549/DC1/.
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